Key Highlights
- USD 16.00 per share was the IPO price set on October 14, 2026 by Iambic Therapeutics (NASDAQ:IAM), the midpoint of a USD 15 to 17 range, raising USD 150.0 million. Published quotes of USD 20.65 to 21.39 are 29.1% to 33.7% above the offer, own arithmetic.
- 12.79% was the gain for PicoCELA (NASDAQ:PCLA) on October 15, 2026, closing at USD 6.70 from USD 5.94 on 50.35 thousand shares and relative volume of 3.46, per exchange data. No company-specific catalyst was identified, and reported going-concern doubt remains.
- 52.7% was the gain for Zenta Group (NASDAQ:ZTG), to USD 0.9511 in the October 16, 2026 premarket per published market data, from a USD 0.62 close, on 104.35 million shares. The company release that day concerns a ZentoAI memorandum of understanding; terms were not available.
- USD 900 million is the all-note price JBDI Holdings (NASDAQ:JBDI) agreed on October 12, 2026 for Glorian Capital, against a USD 28 million market value. Published market data show a 26.71% gain to USD 2.97 on October 16, with no new filing behind it.
Iambic Therapeutics (NASDAQ:IAM)
Iambic is the only conventional new issue in the group. It priced 9,375,000 shares at USD 16.00 on October 14, 2026, for USD 150.0 million of gross proceeds, before an option for 1,406,250 more shares, per the prospectus. The offer was not upsized, and J.P. Morgan, Jefferies, BofA Securities and Citigroup led it. Trading opened at USD 19.31, 20.7% above the offer, and reached USD 22.00. One provider shows USD 21.39 after a 13.11% move, which implies a USD 18.91 reference that does not tie to the offer, own arithmetic. The company uses an AI-enabled platform to design small-molecule cancer drugs, led by IAM1363, an oral HER2 inhibitor in a Phase 1/1b trial. Cash was USD 207.9 million at June 30, 2026, against a first-half net loss of USD 50.1 million. With 47,400,796 shares outstanding, USD 20.65 values the company at USD 978.8 million, own arithmetic. Iambic Therapeutics (NASDAQ:IAM) faces early-stage trial risk and selling when lock-up periods end, whose length is not disclosed. Analyst initiations after the quiet period and the underwriters' 30-day option are the next dated events.
PicoCELA (NASDAQ:PCLA)
PicoCELA is a Japan-based maker of wireless mesh access points whose American depositary shares listed on Nasdaq on January 16, 2025. Fiscal 2025 revenue was JPY 544.69 million, down 30.56%, with a loss of JPY 626.31 million, per reported annual figures. A July 2026 preferred stock sale reportedly raised USD 5 million gross at USD 0.25 per share. The shares convert one to one, rising to one to two if the price stays at or below USD 0.50 for 20 consecutive trading days, so a lower price means more shares. The depositary ratio is not disclosed, so USD 0.25 is not comparable with the USD 6.70 close. Turnover on October 15 was USD 0.34 million, 0.52% of the USD 64.41 million market capitalization, own arithmetic. That market capitalization is 15.5 times trailing revenue of USD 4.15 million, own arithmetic. A transfer restriction reportedly ends on October 30, 2026, which could add supply. PicoCELA (NASDAQ:PCLA) closed 65.8% below its USD 19.61 52-week high, own arithmetic, so the gain is small against the earlier slide.
Zenta Group (NASDAQ:ZTG)
Zenta Group has traded on the Nasdaq Capital Market since September 9, 2025. On September 9, 2026 it agreed to buy ZentoAI, a Macau AI research and tourism app company, for USD 5,844,490 in restricted shares at USD 0.476 plus HKD 10,000,000 in cash. The deal is related-party, because chairman and chief executive Ng Wai Ian also chairs ZentoAI. On September 24 the company said ZentoAI had zero confirmed customer orders, and on October 13 it announced an AI and data refocus. Turnover of USD 99.2 million at USD 0.9511 is 589% of the USD 16.85 million market capitalization, own arithmetic. The relative volume of 88.07 is a data-provider figure not independently confirmed. Nasdaq allows a bid deficiency notice after 30 consecutive business days below USD 1.00, and Zenta Group (NASDAQ:ZTG) is 4.9% below that level, own arithmetic. No notice was identified through October 16, 2026. A USD 50 million shelf filed on September 22 equals 297% of market capitalization, own arithmetic, and goodwill from ZentoAI may face a write-down.
JBDI Holdings (NASDAQ:JBDI)
JBDI Holdings, a Singapore reconditioner of steel and plastic drums, signed a share purchase agreement on October 12, 2026 for Glorian Capital, owner of the ZYMIX social app. Payment is in perpetual, interest-free senior unsecured notes convertible at USD 1.00 per share, so full conversion implies up to 900 million shares against 9.51 million outstanding, 94.6 times, own arithmetic. A 40% voting cap limits control, not economic dilution. The filing states USD 900 million is not a forecast of revenue or earnings, and trailing revenue of USD 8.52 million makes the price 105.6 times revenue, own arithmetic. Holders may demand redemption at 101% of principal after a fundamental change. Nasdaq Rule 5635 approvals are required, an October 22, 2026 meeting covers a dual-class structure, and closing is expected on October 30. JBDI Holdings (NASDAQ:JBDI) received a bid notice on January 7, 2026, completed a 1-for-2 reverse split in June 2026 and said on July 15 that Nasdaq had confirmed compliance. Turnover on October 16 was USD 6.47 million, 23% of market value, own arithmetic.
Where Things Stand
Iambic, PicoCELA, Zenta and JBDI are rallying, and only Iambic is a conventional IPO. Own arithmetic ranks gain from each stated reference: Zenta 52.7% from the October 15 close, Iambic 29.1% to 33.7% above its offer, JBDI 26.71% on October 16 and PicoCELA 12.79% on October 15. Bases differ, so the ranking is indicative. Turnover as a share of market capitalization is 589% for Zenta Group (NASDAQ:ZTG), 23% for JBDI and 0.52% for PicoCELA, and is not available for Iambic. Iambic Therapeutics (NASDAQ:IAM) has the strongest funding. PicoCELA (NASDAQ:PCLA) carries going-concern doubt. Next: Iambic analyst initiations, the October 22 JBDI meeting and the October 30 PicoCELA restriction expiry.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...